Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Disc Medicine Inc (IRON)
Disc Medicine Inc (IRON) News

IRON

Disc Medicine (IRON)

Disc Medicine Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
11/20/2024	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IRON	Disc Medicine Inc
11/19/2024	6:46PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
11/15/2024	4:47PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IRON	Disc Medicine Inc
11/15/2024	4:43PM	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:IRON	Disc Medicine Inc
11/15/2024	4:39PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
11/15/2024	4:31PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
11/14/2024	5:44PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:IRON	Disc Medicine Inc
11/14/2024	4:33PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:IRON	Disc Medicine Inc
11/13/2024	8:30AM	GlobeNewswire Inc.	Disc Medicine to Participate in Upcoming Investor Conferences	NASDAQ:IRON	Disc Medicine Inc
11/12/2024	8:00AM	GlobeNewswire Inc.	Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
11/08/2024	2:17PM	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:IRON	Disc Medicine Inc
11/08/2024	8:49AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
11/08/2024	8:30AM	GlobeNewswire Inc.	Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.	NASDAQ:IRON	Disc Medicine Inc
11/05/2024	9:00AM	GlobeNewswire Inc.	Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
11/04/2024	7:55AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
11/04/2024	7:50AM	GlobeNewswire Inc.	Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval	NASDAQ:IRON	Disc Medicine Inc
11/01/2024	4:01PM	GlobeNewswire Inc.	Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)	NASDAQ:IRON	Disc Medicine Inc
10/25/2024	1:11PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
10/25/2024	1:00PM	GlobeNewswire Inc.	Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week	NASDAQ:IRON	Disc Medicine Inc
10/24/2024	2:02PM	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:IRON	Disc Medicine Inc
10/23/2024	8:00AM	GlobeNewswire Inc.	Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer	NASDAQ:IRON	Disc Medicine Inc
10/11/2024	8:00AM	GlobeNewswire Inc.	Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week	NASDAQ:IRON	Disc Medicine Inc
09/19/2024	8:30AM	GlobeNewswire Inc.	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer	NASDAQ:IRON	Disc Medicine Inc
09/18/2024	4:05PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
09/16/2024	4:39PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
09/04/2024	4:05PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
09/03/2024	4:15PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
08/30/2024	8:00AM	GlobeNewswire Inc.	Disc Medicine to Participate in Upcoming Investor Conferences	NASDAQ:IRON	Disc Medicine Inc
08/08/2024	9:23AM	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:IRON	Disc Medicine Inc
08/08/2024	8:15AM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IRON	Disc Medicine Inc

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 4 5 6 Next >>

Global Developments (PK)

Baron Capital Enterprise (CE)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Rennova Health (CE)

Lightwave Logic

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions